On Friday, WP Glimcher Inc (NYSE:WPG)’s shares inclined 0.83% to $13.40.
WP Glimcher Inc (WPG) declared that the Company has entered into a new 5-year, $500 million term loan. The Company used the proceeds to fully repay the remainder of the Company’s outstanding bridge loan that was used to finance the January 2015 acquisition of Glimcher Realty Trust and for other general corporate purposes.
The aggregate principal balance of the term loan will be due upon maturity on March 2, 2020. The loan bears interest at LIBOR plus 1.15% based on the Company’s current debt rating. The Company expects to fix all or a portion of the variable interest rate exposure on the term loan by entering into an interest swap arrangement in the near term.
Washington Prime Group Inc. (NYSE:WPG.WI) operates independently of Simon Property Group Inc. as of May 28, 2014.
Boardwalk Pipeline Partners, LP (NYSE:BWP)’s shares dropped -0.59% to $15.17.
Boardwalk Pipeline Partners, LP (BWP) and certain of its wholly-owned auxiliaries reached a Third Amended and Restated Revolving Credit Agreement (the “Amended Credit Agreement”) among the Partnership, as guarantor, Boardwalk Pipelines, LP, Texas Gas Transmission, LLC, Gulf South Pipeline Company, LP and Gulf Crossing Pipeline Company LLC, as borrowers (the “Borrowers”), and the several lenders and issuers party thereto (the “Lenders”), Wells Fargo Bank, N.A., as administrative agent, Citibank, N.A. and JPMorgan Chase Bank, N.A., as co-syndication agents and the other agents identified therein. Under the Amended Credit Agreement, the Lenders will provide the Borrowers certain revolving loans, swingline loans and letters of credit to be used for general partnership purposes, counting repayment of indebtedness, acquisitions, capital expenditures and payment of distributions, in an aggregate amount of up to $1.5 billion. Each Borrower is subject to a separate sublimit for borrowings under this facility. The Partnership has guaranteed the obligations of the Borrowers under the Amended Credit Agreement.
Boardwalk Pipeline Partners, LP is a limited partnership company. The Company’s business is conducted by its primary partner, Boardwalk Pipelines, LP (Boardwalk Pipelines) and its auxiliaries Gulf Crossing Pipeline Company LLC, Gulf South Pipeline Company, LP, Texas Gas Transmission, LLC, Boardwalk Field Services, LLC, Petal Gas Storage, L.L.C, Boardwalk Louisiana Midstream, LLC and Boardwalk Storage Company, LLC. The Company’s business comprises integrated natural gas and natural gas liquids (NGLs) pipeline and storage systems and natural gas gathering and processing.
At the end of Friday’s trade, Synthetic Biologics Inc (NYSEMKT:SYN)‘s shares surged 6.87% to $2.80.
Synthetic Biologics Inc (SYN) a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, dosed the first participant in a second Phase 2a clinical trial of SYN-004. This trial will evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, in the presence of the proton pump inhibitor (PPI), esomeprazole. SYN-004 is the Company’s candidate therapy designed to degrade certain intravenous (IV) beta-lactam antibiotics within the GI tract and maintain the natural balance of the gut microbiome for the prevention of C. difficile infection, antibiotic-associated diarrhea (AAD) and secondary antibiotic-resistant infections.
PPIs are often used prophylactic ally in hospitalized patients. Therefore, with guidance from the U.S. Food and Drug Administration (FDA), Synthetic Biologics is conducting this study to demonstrate the ability of SYN-004 to degrade an intravenous (IV) antibiotic in the presence of a PPI.
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV) antibiotics for the prevention of C. difficile infection; an oral statin treatment to reduce the impact of methane producing organisms on irritable bowel syndrome with constipation (IBS-C); and a monoclonal antibody combination for the treatment of Pertussis.
Darden Restaurants, Inc. (NYSE:DRI), ended its Friday’s trading session with 1.58 gain, and closed at $68.11.
Olive Garden is a division of Darden Restaurants, Inc. (DRI). is introducing another way for guests to enjoy its iconic breadsticks with a new menu offering – Signature Breadstick Bun Sandwiches served with fries and choice of unlimited homemade soup or Famous House Salad. Startning recently, guests can satisfy their lunchtime cravings with one of two Breadstick Bun Sandwiches, starting at just $6.99.
The much-anticipated Signature Breadstick Bun Sandwiches have been making headlines with fans across the nation looking forward to their first taste. That’s why Olive Garden is inviting guests to celebrate the new menu offering throughout the summer with Breadstick Nation – a seven-week-long nationwide tour of four Olive Garden food trucks that will be giving away free samples of the Signature Breadstick Bun Sandwiches. The tour will hit the road recently with one food truck in New York City and will be joined by additional trucks visiting 20 cities nationwide.
Darden Restaurants, Inc. owns and operates full service restaurants in the United States and Canada. It operates restaurants under the Olive Garden, LongHorn Steakhouse, Bahama Breeze, Seasons 52, The Capital Grille, Eddie V’s, and Yard House brand names. As of July 28, 2014, it owned and operated about 1,500 restaurants. The company was founded in 1968 and is headquartered in Orlando, Florida.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
